Mobile

Inhaled pre-prandial human insulin with the AERx® iDMS versus s.c. insulin aspart in type 2 diabetes: A 104-week, open-label, multicentre, randomised trial followed by 12-week re-randomised extension ...

Mise à jour : Il y a 4 ans
Référence : EUCTR2005-005378-58

Inhaled pre-prandial human insulin with the AERx® iDMS versus s.c. insulin aspart in type 2 diabetes: A 104-week, open-label, multicentre, randomised trial followed by 12-week re-randomised extension to investigate safety and efficacy

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To compare the effect of pre-prandial inhaled human insulin administered with AERx to subcutaneous injections of pre-prandial insulin aspart (both in combination with insulin detemir) on glycaemic control (as measured by change in HbA1c from baseline) in subjects with type 2 diabetes after 52 weeks treatment.

Critère d'inclusion

  • Diabetes Mellitus

Liens